IME

IMEXHS FPO [IME]
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. The company operates in two segments: Software and Radiology. It offers medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; and ANTEROS, a cardiology software solution. It also provides radiological diagnostic services to hospitals and medical facilities; medical images and radiologists' interpretation; reports to develop artificial intelligence (AI) tools; and outsourced radiology services, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is based in Sydney, Australia.
Healthcare · ASX Small Cap
$0.3550 +1.4%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-19
Get alerts when IME triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track IME — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Trading above both moving averages — the trend is your friend here
  • Volume surging at 3.5x normal while price climbs — real buying conviction behind this move
  • Just broke above 20-day resistance — a level that was capping price, now cleared
  • Beating the Small Ords index — relative strength of 1.19, so it's outpacing the pack
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.6x)
  • Moderate revenue growth (+17%)
  • Piotroski F-Score strong (7/9, low-confidence approx)
  • EPS estimates revised upward (+10pts)
  • Micro-cap ($5-20M) - high risk
  • CANSLIM S: Tight float (48%)
  • Revenue declined -57% YoY
  • Sentiment is mixed — no strong consensus either way
  • The bigger volume days are the up days — volume-weighted momentum is positive (2.31%/day)
  • Liquidity risk: 6 zero-volume days in last 20
  • Beneish M-Score -2.13 (grey zone -2.22 to -1.78): possible earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • RSI is running hot — overbought territory, so expect some pullback risk
  • Stochastic is stretched into overbought — could need a breather
  • RSI is overbought but volume confirms it — this could be genuine momentum, not just froth
  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral

Recent Catalysts

NONE H1 FY26 Results Presentation
NONE Notification of cessation of securities - IME
NONE Notice of 1H FY26 Results Presentation

Recent ASX Announcements

2026-09-01 H1 FY26 Results Presentation PRICE SENSITIVE
2026-09-01 Notification of cessation of securities - IME
2026-08-28 Notice of 1H FY26 Results Presentation
2026-08-27 IMEXHS Reports 1H FY26 Results PRICE SENSITIVE
2026-08-27 Half Yearly Report and Accounts PRICE SENSITIVE

Key Metrics

$19.3M
Market Cap
5K
Avg Volume
3.5x
Vol Ratio
$0.23 — $0.47
52-Week Range
N/A
Short Interest
N/A
Cash Runway
1.2%
ROE
0.6%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 48%
LLeader vs LaggardlaggardRS: -4
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
CAN +25.0%MEM +20.0%BIT -16.7%CSX +10.5%ENL -10.0%
Compare:IME vs CANIME vs MEMIME vs BIT
Share this analysis

Track IME and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required